Philip S. Wang
Department of Psychiatry
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital
Harvard Medical School
USA
Name/email consistency: high
- Psychotropic medication use for behavioral symptoms of dementia. Wang, P.S., Brookhart, M.A., Setoguchi, S., Patrick, A.R., Schneeweiss, S. Curr. Neurol. Neurosci. Rep (2006)
- Suboptimal antidepressant use in the elderly. Wang, P.S., Schneeweiss, S., Brookhart, M.A., Glynn, R.J., Mogun, H., Patrick, A.R., Avorn, J. J. Clin. Psychopharmacol (2005)
- Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Wang, P.S., Avorn, J., Brookhart, M.A., Mogun, H., Schneeweiss, S., Fischer, M.A., Glynn, R.J. Hypertension (2005)
- Risk of death in elderly users of conventional vs. atypical antipsychotic medications. Wang, P.S., Schneeweiss, S., Avorn, J., Fischer, M.A., Mogun, H., Solomon, D.H., Brookhart, M.A. N. Engl. J. Med. (2005)
- How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Wang, P.S., Benner, J.S., Glynn, R.J., Winkelmayer, W.C., Mogun, H., Avorn, J. Pharmacoepidemiol. Drug. Saf (2004)
- Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. Wang, P.S., Schneeweiss, S., Glynn, R.J., Mogun, H., Avorn, J. Ann. Epidemiol (2004)
- Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model. Wang, P.S., Ganz, D.A., Benner, J.S., Glynn, R.J., Avorn, J. J. Ment. Health. Policy. Econ (2004)
- The economic burden of depression and the cost-effectiveness of treatment. Wang, P.S., Simon, G., Kessler, R.C. Int. J. Methods. Psychiatr. Res (2003)
- Adequacy of treatment for serious mental illness in the United States. Wang, P.S., Demler, O., Kessler, R.C. Am. J. Public. Health (2002)
- Clozapine use and risk of diabetes mellitus. Wang, P.S., Glynn, R.J., Ganz, D.A., Schneeweiss, S., Levin, R., Avorn, J. J. Clin. Psychopharmacol (2002)
- Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. Wang, P.S., Bohn, R.L., Knight, E., Glynn, R.J., Mogun, H., Avorn, J. J. Gen. Intern. Med (2002)
- Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Wang, P.S., Bohn, R.L., Glynn, R.J., Mogun, H., Avorn, J. Am. J. Psychiatry (2001)
- Finding incident breast cancer cases through US claims data and a state cancer registry. Wang, P.S., Walker, A.M., Tsuang, M.T., Orav, E.J., Levin, R., Avorn, J. Cancer. Causes. Control (2001)
- Antidepressant use and the risk of breast cancer: a non-association. Wang, P.S., Walker, A.M., Tsuang, M.T., Orav, E.J., Levin, R., Avorn, J. J. Clin. Epidemiol (2001)
- HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. Wang, P.S., Solomon, D.H., Mogun, H., Avorn, J. JAMA (2000)
- Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. Wang, P.S., Walker, A., Tsuang, M., Orav, E.J., Levin, R., Avorn, J. J. Clin. Epidemiol (2000)
- Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders. Wang, P.S., West, J.C., Tanielian, T., Pincus, H.A. Schizophr. Bull (2000)